中国学者近期发表的论文
1.	Biological background of the genomic variations of cf-DNA in healthy individuals. Author: Liu J1,2, Chen X3, Wang J4,5, Zhou S1, Wang CL1, Ye MZ6, Wang XY1, Song Y1, Wang YQ1, Zhang LT1, Wu RH1, Yang HM4,5, Zhu SD4, Zhou MZ6, Zhang XC7, Zhu HM3, Qian ZY3. Journal: Ann Oncol. 2019 Mar 1;30(3):464-470. doi: 10.1093/annonc/mdy513.    PubMed      DOI
2.	Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. Author: Muro K1, Van Cutsem E2, Narita Y1, Pentheroudakis G3, Baba E4, Li J5, Ryu MH6, Zamaniah WIW7, Yong WP8, Yeh KH9,10, Kato K11, Lu Z12, Cho BC13, Nor IM14, Ng M15, Chen LT16, Nakajima TE17, Shitara K18, Kawakami H19, Tsushima T20, Yoshino T18, Lordick F21,22, Martinelli E23, Smyth EC24, Arnold D25, Minami H26, Tabernero J27, Douillard JY28. Journal: Ann Oncol. 2019 Jan 1;30(1):19-33. doi: 10.1093/annonc/mdy502.    PubMed      DOI
3.	Virtual microdissection in the molecular subtyping of head and neck squamous carcinoma-a 'Virtual Reality' of the tumor microenvironment? Author: Ma BBY1. Journal: Ann Oncol. 2019 Jan 1;30(1):8-10. doi: 10.1093/annonc/mdy516.    PubMed      DOI
4.	Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS. Author: Wu YL1, Planchard D2, Lu S3, Sun H4, Yamamoto N5, Kim DW6, Tan DSW7, Yang JC8, Azrif M9, Mitsudomi T10, Park K11, Soo RA12, Chang JWC13, Alip A14, Peters S15, Douillard JY16. Journal: Ann Oncol. 2019 Feb 1;30(2):171-210. doi: 10.1093/annonc/mdy554.    PubMed      DOI
5.	HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib. Author: Wang Y1, Jiang T1, Qin Z2, Jiang J3, Wang Q3, Yang S1, Rivard C4, Gao G1, Ng TL4, Tu MM5,6, Yu H4, Ji H1,2, Zhou C1, Ren S1,4, Zhang J7, Bunn P4, Doebele RC4, Camidge DR4, Hirsch FR4. Journal: Ann Oncol. 2019 Mar 1;30(3):447-455. doi: 10.1093/annonc/mdy542.    PubMed      DOI
6.	Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Author: Dong D1,2,3, Tang L2, Li ZY4, Fang MJ1,3, Gao JB5, Shan XH6, Ying XJ4, Sun YS2, Fu J2, Wang XX6, Li LM5, Li ZH7, Zhang DF7, Zhang Y4, Li ZM4, Shan F4, Bu ZD4, Tian J1,3,8, Ji JF4. Journal: Ann Oncol. 2019 Mar 1;30(3):431-438. doi: 10.1093/annonc/mdz001.    PubMed      DOI
7.	OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer. Author: Robson ME1, Tung N2, Conte P3, Im SA4, Senkus E5, Xu B6, Masuda N7, Delaloge S8, Li W9, Armstrong A10, Wu W11, Goessl C11, Runswick S12, Domchek SM13. Journal: Ann Oncol. 2019 Apr 1;30(4):558-566. doi: 10.1093/annonc/mdz012.    PubMed      DOI
8.	Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial. Author: Zhao C1,2, Miao J2, Shen G3,4, Li J5, Shi M6, Zhang N7, Hu G8, Chen X9, Hu X7, Wu S10, Chen J11, Shao X3, Wang L2, Han F12, Mai H2, Chua MLK13,14, Xie C1. Journal: Ann Oncol. 2019 Apr 1;30(4):637-643. doi: 10.1093/annonc/mdz020.    PubMed      DOI
9.	Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3). Author: Zuo H1, Ueland PM2,3, Midttun Ø4, Tell GS1, Fanidi A5,6, Zheng W7, Shu X7, Xiang Y8, Wu J7, Prentice R9, Pettinger M9, Thomson CA10, Giles GG11,12, Hodge A11,12, Cai Q7, Blot WJ7, Johansson M13, Hultdin J14, Grankvist K14, Stevens VL15, McCullough ML15, Weinstein SJ16, Albanes D16, Ziegler RG16, Freedman ND16, Caporaso NE16, Langhammer A17, Hveem K17, Næss M17, Buring JE18,19, Lee I18,19, Gaziano JM20,21, Severi G22,23, Zhang X24, Stampfer MJ24,19,25, Han J26, Zeleniuch-Jacquotte A27, Marchand LL28, Yuan J29,30, Wang R29, Koh W31, Gao Y32, Ericson U33, Visvanathan K34, Jones MR34, Relton C35,36, Brennan P5, Johansson M5, Ulvik A4. Journal: Ann Oncol. 2019 Mar 1;30(3):478-485. doi: 10.1093/annonc/mdz002.    PubMed      DOI
10.	31PComprehensive genomic profiling of Chinese esophageal squamous cell carcinoma patients. Author: Ji Y1, Wu Y2, Fu W3, Liu L4, Tian Z5, Wen S5, Zhang K6, Yao M7, Liu A7, Zhou Y7. Journal: Ann Oncol. 2019 Feb 1;30(Supplement_1). pii: mdz026.002. doi: 10.1093/annonc/mdz026.002.    PubMed      DOI

同类著名期刊名称 h-index CiteScore CA-A CANCER JOURNAL FOR CLINICIANS 144 160.19 Nature Reviews Clinical Oncology 127 8.04 NATURE REVIEWS CANCER 396 23.23 LANCET ONCOLOGY 274 10.07 JOURNAL OF CLINICAL ONCOLOGY 494 11.08 CANCER CELL 295 15.04 SEMINARS IN CANCER BIOLOGY 134 8.86 CLINICAL CANCER RESEARCH 292 8.32 CANCER RESEARCH 411 6.94 CANCER TREATMENT REVIEWS 116 8.69

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 283108 CANCER RESEARCH 163375 International Journal of Nanomedicine 161743 Molecular Medicine Reports 161509 CANCER LETTERS 156808 JOURNAL OF ETHNOPHARMACOLOGY 138629 BIOMEDICINE & PHARMACOTHERAPY 136458 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 133241 Theranostics 132424 International Journal of Environmental Research and Public Health 130921